Comparing anti-Mullerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function
被引:96
作者:
Barad, David H.
论文数: 0引用数: 0
h-index: 0
机构:
Ctr Human Reprod, New York, NY 10021 USA
Albert Einstein Coll Med, Dept Epidemiol & Social Med, Bronx, NY 10467 USA
Albert Einstein Coll Med, Dept Obstet Gynecol & Womens Hlth, Bronx, NY 10467 USACtr Human Reprod, New York, NY 10021 USA
Barad, David H.
[1
,2
,3
]
Weghofer, Andrea
论文数: 0引用数: 0
h-index: 0
机构:
Ctr Human Reprod, New York, NY 10021 USA
Univ Vienna, Sch Med, Allgemeines Krankenhaus, Dept Obstet & Gynecol, Vienna, AustriaCtr Human Reprod, New York, NY 10021 USA
Weghofer, Andrea
[1
,4
]
Gleicher, Norbert
论文数: 0引用数: 0
h-index: 0
机构:
Ctr Human Reprod, New York, NY 10021 USA
Yale Univ, Sch Med, Dept Obstet Gynecol & Reproduct Sci, New Haven, CT USACtr Human Reprod, New York, NY 10021 USA
Gleicher, Norbert
[1
,5
]
机构:
[1] Ctr Human Reprod, New York, NY 10021 USA
[2] Albert Einstein Coll Med, Dept Epidemiol & Social Med, Bronx, NY 10467 USA
[3] Albert Einstein Coll Med, Dept Obstet Gynecol & Womens Hlth, Bronx, NY 10467 USA
We compared predictive values of anti-Mullerian hormone (AMH) and baseline FSH with respect to IVF cycle outcomes based on oocyte numbers retrieved and number of clinical pregnancies established. In 76 IVF cycles investigated, AMH was clearly superior in predicting IVF outcomes in comparison with FSH. (Fertil Steril (R) 2009;91:1553-5. (C) 2009 by American Society for Reproductive Medicine.)